Compounds represented by Formula (I): ##STR00001## or stereoisomers or
pharmaceutically acceptable salts thereof, are inhibitors of least two of
the Abl, Aurora-A, Blk, c-Raf, cSRC, Src, PRK2, FGFR3, Flt3, Lck, Mek1,
PDK-1, GSK3.beta., EGFR, p70S6K, BMX, SGK, CaMKII, Tie-2, IGF-1R, Ron,
Ret, and KDR kinases in animals, including humans, for the treatment
and/or prevention of various diseases and conditions such as cancer.